Daniel Savic
Cited by
Cited by
Distinct properties of cell-type-specific and shared transcription factor binding sites
J Gertz, D Savic, KE Varley, EC Partridge, A Safi, P Jain, GM Cooper, ...
Molecular cell 52 (1), 25-36, 2013
Expanded encyclopaedias of DNA elements in the human and mouse genomes
JE Moore, MJ Purcaro, HE Pratt, CB Epstein, N Shoresh, J Adrian, T Kawli, ...
Nature 583 (7818), 699-710, 2020
Transcriptional enhancers in development and disease
NJ Sakabe, D Savic, MA Nobrega
Genome biology 13 (1), 1-11, 2012
Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism
D Savic, H Ye, I Aneas, SY Park, GI Bell, MA Nobrega
Genome research 21 (9), 1417-1425, 2011
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells
SW Paugh, EJ Bonten, D Savic, LB Ramsey, WE Thierfelder, P Gurung, ...
Nature genetics 47 (6), 607-614, 2015
CETCh-seq: CRISPR epitope tagging ChIP-seq of DNA-binding proteins
D Savic, EC Partridge, KM Newberry, SB Smith, SK Meadows, BS Roberts, ...
Genome research 25 (10), 1581-1589, 2015
Genomic regulation of invasion by STAT3 in triple negative breast cancer
JM McDaniel, KE Varley, J Gertz, DS Savic, BS Roberts, SK Bailey, ...
Oncotarget 8 (5), 8226, 2017
CCCTC-binding factor translates interleukin 2-and α-ketoglutarate-sensitive metabolic changes in T cells into context-dependent gene programs
DA Chisolm, D Savic, AJ Moore, A Ballesteros-Tato, B León, ...
Immunity 47 (2), 251-267. e7, 2017
Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation
D Savic, RC Ramaker, BS Roberts, EC Dean, TC Burwell, SK Meadows, ...
Genome medicine 8 (1), 1-16, 2016
Evidence of non-pancreatic beta cell-dependent roles of Tcf7l2 in the regulation of glucose metabolism in mice
KA Bailey, D Savic, M Zielinski, SY Park, L Wang, P Witkowski, M Brady, ...
Human molecular genetics 24 (6), 1646-1654, 2015
Occupancy maps of 208 chromatin-associated proteins in one human cell type
EC Partridge, SB Chhetri, JW Prokop, RC Ramaker, CS Jansen, ST Goh, ...
Nature 583 (7818), 720-728, 2020
Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/enhancer-binding protein beta binding sites
D Savic, BS Roberts, JB Carleton, EC Partridge, MA White, BA Cohen, ...
Genome research 25 (12), 1791-1800, 2015
Mapping genome-wide transcription factor binding sites in frozen tissues
D Savic, J Gertz, P Jain, GM Cooper, RM Myers
Epigenetics & chromatin 6 (1), 1-10, 2013
Perspectives on ENCODE
MP Snyder, TR Gingeras, JE Moore, Z Weng, MB Gerstein, B Ren, ...
Nature 583 (7818), 693-698, 2020
Modulation of Tcf7l2 expression alters behavior in mice
D Savic, MG Distler, G Sokoloff, NA Shanahan, SC Dulawa, AA Palmer, ...
PLoS One 6 (10), e26897, 2011
Batf pioneers the reorganization of chromatin in developing effector T cells via Ets1-dependent recruitment of Ctcf
D Pham, CE Moseley, M Gao, D Savic, CJ Winstead, M Sun, BL Kee, ...
Cell reports 29 (5), 1203-1220. e7, 2019
An in vivo cis-regulatory screen at the type 2 diabetes associated TCF7L2 locus identifies multiple tissue-specific enhancers
D Savic, GI Bell, MA Nobrega
PLoS One 7 (5), e36501, 2012
In vitro scan for enhancers at the TCF7L2 locus
D Savic, SY Park, KA Bailey, GI Bell, MA Nobrega
Diabetologia 56 (1), 121-125, 2013
Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia
RJ Autry, SW Paugh, R Carter, L Shi, J Liu, DC Ferguson, CE Lau, ...
Nature cancer 1 (3), 329-344, 2020
Decoding transcriptional enhancers: Evolving from annotation to functional interpretation
KL Engel, M Mackiewicz, AA Hardigan, RM Myers, D Savic
Seminars in cell & developmental biology 57, 40-50, 2016
The system can't perform the operation now. Try again later.
Articles 1–20